A large number of data obtained in the process of genetic sequencing can be widely used in clinical diagnosis and treatment after rapid analysis and structural integration. The precision medicine based on big data will become an inevitable trend of the medical development in the future, and will play an increasingly important role.

Considerin has taken the lead in creating the “gene sequencing + precision medicine big data” model through strategic alliance with Vishuo, a global leader of big data genetic analysis and model building. Considerin is committed to benefiting the public through its high-end gene sequencing technology, and is currently capable of providing its clients with precision medicine gene sequencing, data analysis, report interpretation and many other services based on PSTAR and iCMDB™ technologies.